Dr Matthew Partridge
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
Latest articles by Dr Matthew Partridge
-
Michel Barnier is the new French PM – so, what now?
After a 'stolen election', Michel Barnier, former EU Brexit negotiator has been appointed as France's new prime minister. What does it mean for France?
By Dr Matthew Partridge Published
-
Takeover bid for Japan's 7-Eleven owner from Canadian chain
The Japanese operator of 7-Eleven convenience stores is being wooed by a Canadian peer. But securing a deal won’t be easy
By Dr Matthew Partridge Published
-
The far-right AfD win big in German elections. So what now?
The far-right AfD celebrate a troubling win in Germany. Should politicians treat this warning seriously?
By Dr Matthew Partridge Published
-
Volkswagen mulls closure of German factories
Why is Volkswagen considering the closures and how is the carmaker performing?
By Dr Matthew Partridge Published
-
The battle against heart disease and how to invest in it
Heart disease is soaring due to rising obesity and an ageing population. But new drugs, treatments and diagnostic tools are on the way.
By Dr Matthew Partridge Published
-
M&S recovery has momentum: will it stick?
After years of decline, M&S seems to have turned a corner. But is this just a “dead cat bounce”?
By Dr Matthew Partridge Published
-
Spread betting for beginners: five trading tips
A short-term trading strategy can complement a long-term investment portfolio, but it can be costly for the unwary and reckless
By Dr Matthew Partridge Published
-
Thornbury Castle: a castle stay with pedigree
MoneyWeek Travel Few stately hotels can rival the fascinating history of Thornbury Castle in Gloucestershire – or the opulence, says Matthew Partridge
By Dr Matthew Partridge Published
MoneyWeek Travel -
Is Alpha Group a good buy?
Alpha Group helps clients manage risks such as foreign exchange. After being promoted to the London Stock Exchange, does the stock still rally?
By Dr Matthew Partridge Published
-
Money talks at the Edinburgh Fringe
Matthew Partridge rounds up the best money-themed shows at the Edinburgh Festival.
By Dr Matthew Partridge Published
-
Kellanova shares surge by 16%
Shares in Pringles maker, Kellanova, hiked by 16% – should you buy?
By Dr Matthew Partridge Published
-
Intel stocks slump – can the chipmaker make a comeback?
Semiconductor maker, Intel, missed the boom in the sector thanks to its focus on PCs. Is it too late to catch up with its rivals?
By Dr Matthew Partridge Published
-
Kamala Harris picks Tim Walz for US election run. Will it make a difference?
Kamala Harris has chosen her running mate – does she have a chance against Trump?
By Dr Matthew Partridge Published
-
BP shares bounce back due to shareholder returns – is it good enough?
BP shareholders can expect to pocket a billion-dollar payout due to unexpectedly high profits. But are investors convinced?
By Dr Matthew Partridge Published
-
Diageo announces first sales slump since the pandemic
British drinks company Diageo seems to have lost its spirits after losing almost a tenth of its shares. Do troubles lie ahead for the Guinness maker?
By Dr Matthew Partridge Published
-
Reckitt Benckiser shares hit 10-year low over baby formula fears
Household goods giant Reckitt Benckiser’s shares slumped after rival Abbott's $495 million baby formula lawsuit. Should investors be worried?
By Dr Matthew Partridge Published
-
Vistry sales improve – should you buy into the boom?
Housebuilder Vistry’s unusual business model has fuelled rapid sales growth amid a sluggish private sales market
By Dr Matthew Partridge Published
-
Maduro clings to power in Venezuela – can he last?
While Maduro clung to his presidential seat, Venezuela's election protests paint a different picture
By Dr Matthew Partridge Published
-
Could Kamala Harris be America's next president?
Kamala Harris is yet to become the Democratic nominee – but when she does, can she beat Trump?
By Dr Matthew Partridge Published
-
Netflix steams ahead of its competitors
Netflix has beaten its rivals, so how can it keep growing?
By Dr Matthew Partridge Published
-
Review: The Bath Priory – a charming stay in an elegant city
MoneyWeek Travel Matthew Partridge visits the Roman ruins and takes the waters at The Bath Priory hotel’s luxurious spa
By Dr Matthew Partridge Published
MoneyWeek Travel -
Donald Trump: America's political violence
The unsettling attack on Donald Trump has meant the US election has taken another dark turn
By Dr Matthew Partridge Published
-
Ocado shares jump by a fifth
Ocado takes a turn for the better after attractive profit forecasts were announced
By Dr Matthew Partridge Published
-
Is local production making a comeback?
Companies return production closer to home and shorten their supply chains due to the pandemic and geopolitical turmoil. How should investors react?
By Dr Matthew Partridge Published